166,613
Participants
Start Date
May 31, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
linagliptin
non-randomized
Boehringer Ingelheim Investigational Site, Boston
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY